Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institutes of Health Clinical Center (CC) |
ClinicalTrials.gov Identifier: | NCT00598286 |
The purpose of this protocol is to measure brain CB1 receptors in the hope to better understand how they work, so that one day we can understand how the CB1 receptors are involved in psychiatric, neurological, and behavioral disorders.
Condition | Intervention |
---|---|
CB1 Cannabinoid PET [18F]FMPEP-d2 Brain Imaging |
Drug: [18F]FMPEP-d2 |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2 |
Estimated Enrollment: | 30 |
Study Start Date: | January 2008 |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
EXCLUSION CRITERIA:
Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
Contact: TTY | 1-866-411-1010 |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
Bethesda, Maryland, United States, 20892 |
Study ID Numbers: | 080049, 08-M-0049 |
Study First Received: | January 10, 2008 |
Last Updated: | March 31, 2009 |
ClinicalTrials.gov Identifier: | NCT00598286 History of Changes |
Health Authority: | United States: Federal Government |
CB1 Receptor PET Cannabinoid [18F]FMPEP-d2 |
Brain Imaging Healthy Volunteer HV |
Healthy |